TABLE 5.
Results of in vitro antifungal susceptibility testing
| Species (no. of isolates) | Drug concn (μg/ml)a |
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMB |
ITC |
PSC |
VRC |
TRB |
NAT |
MICA |
ANID |
CAS |
||||||||||
| MIC50 | MIC90 | MIC50 | MIC90 | MIC50 | MIC90 | MIC50 | MIC90 | MIC50 | MIC90 | MIC50 | MIC90 | MEC50 | MEC90 | MEC50 | MEC90 | MEC50 | MEC90 | |
| A. kiliense (15) | 4 | 16 | >16 | >16 | 4 | >16 | 2 | 4 | 1 | 2 | 8 | 8 | >16 | >16 | >16 | >16 | >16 | >16 |
| A. sclerotigenum- | ||||||||||||||||||
| A. egyptiacum (11) | 4 | 16 | >16 | >16 | 1 | 2 | 2 | 2 | 0.125 | 0.5 | 8 | 16 | >16 | >16 | >16 | >16 | >16 | >16 |
| A. implicatum (7) | 2 | 4 | >16 | >16 | 2 | >16 | 2 | 8 | 0.25 | 1 | 4 | 8 | >16 | >16 | >16 | >16 | >16 | >16 |
| A. persicinum (7) | 2 | 8 | >16 | >16 | 1 | 8 | 2 | 8 | 0.125 | 0.25 | 4 | 8 | >16 | >16 | >16 | >16 | >16 | >16 |
| A. atrogriseum (4) | 1 | 2 | 4 | 8 | 1 | 2 | 2 | 2 | 0.125 | 0.125 | 2 | 4 | 0.125 | >16 | 0.5 | >16 | 0.5 | >16 |
| A. fusidioides (3) | 2 | 2 | 1 | >16 | 1 | 2 | 2 | 2 | 0.125 | 2 | 4 | 4 | 4 | >16 | 4 | >16 | 4 | >16 |
a
AMB, amphotericin B; ANID, anidulafungin; CAS, caspofungin; ITC, itraconazole; MICA, micafungin; NAT, natamycin; PSC, posaconazole; TRB, terbinafine; VRC, voriconazole.